Citation Impact

Citing Papers

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
2003 Standout
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
TOR Signaling in Growth and Metabolism
2006 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Breast cancer
2019 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Targeting the mTOR signaling network in cancer
2007
Endometrial Carcinomas
2011
Oncogenic kinase signalling
2001 StandoutNature
DNA methylation in endometrial cancer
2010
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
1999
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
2002 StandoutNature
Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
1999
The Hallmarks of Cancer
2000 Standout
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
1998 StandoutNobel
Phosphoinositide 3-Kinase-mediated Activation of Cofilin Phosphatase Slingshot and Its Role for Insulin-induced Membrane Protrusion
2004 StandoutNobel
PTEN: One Gene, Many Syndromes
2003
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing
2008
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
1997
PTEN expression in non–small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration
2005
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
The effect Akt2 deletion on tumor development in Pten+/− mice
2011
The GH/IGF-1 axis in ageing and longevity
2013
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
Heritability and molecular genetic studies of endometriosis
2000
The microenvironment of the tumour–host interface
2001 StandoutNature
The emerging roles of forkhead box (Fox) proteins in cancer
2007
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Malignant Gliomas in Adults
2008 Standout
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis
2003 StandoutNobel
PTEN: Life as a Tumor Suppressor
2001
Genetic basis of Cowden syndrome and its implications for clinical practice and risk management
2016
Mutations of the human PTEN gene
2000
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines
2003
Inactivation of thePTEN/MMAC1/TEP1 gene in human lung cancers
1998
Endometriosis
2004 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
AKT/PKB Signaling: Navigating the Network
2017 Standout
Protein Tyrosine Phosphatases in the Human Genome
2004 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Use of mutation profiles to refine the classification of endometrial carcinomas
2012
The PI3K Pathway in Human Disease
2017 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Comprehensive identification of mutational cancer driver genes across 12 tumor types
2013
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
2001 StandoutNobel
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
1999 Standout
Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase
2000 Standout
Protein tyrosine phosphatases
2002
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
1998
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
1999
AKT/PKB and Other D3 Phosphoinositide-Regulated Kinases: Kinase Activation by Phosphoinositide-Dependent Phosphorylation
1999
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
2004
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
2003 StandoutNobel
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Spermidine in health and disease
2018 StandoutScience
Integrin Signaling
1999 StandoutScience
Germline PTEN mutations in Cowden syndrome-like families.
1998
The molecular biology of chronic myeloid leukemia
2000
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
1998
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
1998
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systems
1999
Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
2000
Forkhead Transcription Factors Are Critical Effectors of Cell Death and Cell Cycle Arrest Downstream of PTEN
2000
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
1998 Standout
Histone H3K27ac separates active from poised enhancers and predicts developmental state
2010 Standout
Genetics of Cowden syndrome: through the looking glass of oncology.
1998
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Regulation of G1progression by thePTENtumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
1999
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development
1999
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
2000 StandoutNobel
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
2006

Works of S Bose being referenced

Immunophenotype of intraductal carcinoma.
1996
Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer
2015
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
2005
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer
2008
Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation.
1998
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
1997
Rankless by CCL
2026